Drug alert: Intravenous dantrolene and the risk of undissolved crystals


MHRA report “Some newly issued vials of intravenous dantrolene may contain crystals of undissolved dantrolene sodium following reconstitution. Draw up the reconstituted solution with a filter needle to prevent these crystals from being administered to patients. There may be a residual increased risk of injection site reactions due to crystals that may not have been removed by filtration; heightened vigilance is therefore required.”

Click here for the full drug safety update.

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page


Comments are closed.